Case in point, the WSJ over the weekend published a piece on how Meta is refocusing its efforts to serve commercial products. My understanding is some of its more "out there" projects will be facing scrutiny. Its bio research team, for example, is one I've heard was impacted.

→ View original post on X — @mattlynley